Association between the Suita Score and Stroke Recurrence in Patients with First-ever Ischemic Stroke: A Prospective

Yoshinori Miyamoto1, Takahiro Itaya2, Yuka Terasawa3

  • 1Department of Cardiology, Brain Attack Center Ota Memorial Hospital, Japan.

Insights

The Suita score, used for coronary heart disease (CHD) risk, effectively predicts one-year stroke recurrence in patients with first-ever ischemic stroke or TIA. High-risk patients identified by the score showed a significantly increased chance of recurrent stroke.

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • The Suita score is established for predicting 10-year coronary heart disease (CHD) risk.
  • Predicting short-term stroke recurrence after a first ischemic event remains a clinical challenge.

Purpose of the Study:

  • To investigate the association between the Suita score and the risk of stroke recurrence within one year following a first-ever ischemic stroke or transient ischemic attack (TIA).

Main Methods:

  • A prospective cohort study involving 1,204 patients admitted for first-ever acute ischemic stroke (AIS) or TIA in Japan.
  • The Suita score was calculated during hospitalization, categorizing patients into high-risk (≥5% predicted CHD risk) and low-risk groups.
  • Multivariate Cox regression analysis was employed to assess the association with 1-year stroke recurrence, adjusting for relevant covariates.

Main Results:

  • A significant proportion (78%) of patients were classified as high-risk for CHD based on the Suita score.
  • Sixty-six patients experienced stroke recurrence within the one-year follow-up period.
  • High predicted CHD risk (≥5% by Suita score) was significantly associated with an increased risk of 1-year stroke recurrence (adjusted HR = 2.20, p=0.049).

Conclusions:

  • The Suita score demonstrates utility in predicting short-term stroke recurrence in patients with first-ever AIS or TIA.
  • This score may serve as a valuable tool for assessing both long-term CHD prognosis and short-term stroke recurrence risk in this patient population.